Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
KP.3.3.3ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
KP.3.3.3ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
KP.3.3.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KP.3.3.3ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
KP.3.3.3ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
KP.3.3.3ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-11502.5China
KP.3.3.3ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
KP.3.3.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.3.3.3SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
KP.3.3.3SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
KP.3.3.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.3.3.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
KP.3.3.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KP.3.3.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.3.3.3NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
KP.3.3.3NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-15598.4US
KP.3.3.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KP.3.3.3NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
KP.3.3.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
KP.3.3.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
KP.3.3.3NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
KP.3.3.3NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
KP.3.3.3ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
ML.2ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
ML.2ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
ML.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
ML.2ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
ML.2ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
ML.2ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-11502.5China
ML.2ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
ML.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
ML.2SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
ML.2SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
ML.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
ML.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
ML.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
ML.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
ML.2NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
ML.2NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-15598.4US
ML.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
ML.2NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
ML.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
ML.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
ML.2NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
ML.2NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
ML.2ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
KP.2.1ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
KP.2.1ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
KP.2.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KP.2.1ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used